Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 147.56
+1.06 (0.72%)
Sep 4, 2026, 4:08 PM GMT
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 124.35 million as of September 4, 2026. Its market cap has increased by 4.96% in one year.
Market Cap
124.35M
Enterprise Value
118.16M
Revenue
38.44M
Ranking
n/a
PE Ratio
1,281.96
Stock Price
147.56
ChartMarket Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 124.35M, an increase of 87.13%. That is a compound annual growth rate of 8.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 124.35M | 14.41% |
| Dec 31, 2025 | 108.69M | 2.47% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Craneware | 470.89M |
| Optima Health | 265.41M |
| MedPal AI | 38.08M |
| Renalytix | 18.14M |
| Cambridge Cognition Holdings | 14.43M |
| Feedback | 3.00M |
| Imaging Biometrics | 1.76M |
| Trellus Health | 172.05K |